Peptide library
EPO
Your guide to this compound.
Dose context
Individual prescription and exact product label; no catalog regimen defaults.
Dosing and preparation are indication- and presentation-specific. Use the linked prescribing information and the individual prescription; no generic dose range is assigned here.
How to read this information
Catalog ranges can describe approved labeling, clinical research or unverified reports. They are not interchangeable and do not select a personal dose.
Half-life
EPOGEN epoetin alfa: IV elimination half-life was 4–13 hours in adults and children with chronic kidney disease. In the cited subcutaneous regimens in anemic cancer patients, mean half-life was about 40 hours (range 16–67). Route, population and regimen differ; the 5–24-hour subcutaneous time to peak is not half-life.
Species, route and formulation matter. Half-life does not define a safe dosing interval.
Routes and frequency in the catalog
Storage
EPOGEN vials: refrigerate 2–8°C in the carton; do not freeze or shake. Single-dose and multidose handling must remain distinct.
Generic storage notes cannot establish a beyond-use date or sterility for a particular vial.
Preparation and reconstitution
Follow the exact presentation’s preparation instructions and supplied diluent. Do not transfer a mixing recipe from another brand or strength.